Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Employer
-
Field
-
Human Stem Cell-based Neural Models is available at the Language & Genetics Department of the Max Planck Institute, Nijmegen, the Netherlands. The position is in the research group of Simon Fisher, co
-
, you will generate and study human induced pluripotent stem cell (hiPSC)-derived cardiomyocytes and engineered cardiac tissues (ECTs). You will develop patient-specific cardiac models to identify
-
for collecting umbilical cord blood from the operating room and isolating CD34+ stem cells from this blood. Through a culturing process, you will expand and differentiate these CD34+ stem cells into large
-
stem cells or stem cell-based biomaterials? And eager to explore cutting-edge technologies like genome editing and in vivo imaging? Or are you perhaps fascinated by eye research and do you have an
-
models using induced pluripotent stem cell (iPSC)-derived kidney organoids. A key aspect of this work will involve integrating bioprinting and organ-on-chip technologies to create mature and
-
cells or stem cell-based biomaterials? And eager to explore cutting-edge technologies like genome editing and in vivo imaging? Or are you perhaps fascinated by eye research and do you have an affinity
-
mouse embryonic stem cells to allow for rapid protein depletion, mapping transcriptional effects (RNA-seq, TT-seq, PRO-seq), proximity labeling approaches, ChIP, and the bioinformatic analysis
-
modelling approaches (https://www.carlier-insilico-lab.com/who-are-we) . Dr LaPointe’s group (www.lapointelab.com ) is dedicated to developing groundbreaking regenerative cell therapies that can transform the
-
contribute directly to this effort by developing patient-specific induced pluripotent stem cell (iPSC)-derived vascular tissues to assess disease severity, drug efficacy and the potential of gene-correction
-
Medicine. Hereditary eye diseases are diagnosed in approximately 100 children annually in the Netherlands. With rapid advances in technologies such as genome editing and induced pluripotent stem cells, new